Cargando…

Determinants of Drug Response in a Cisplatin‐resistant Human Lung Cancer Cell Line

To elucidate the mechanism(s) of cisplatin resistance, we have characterized a human non‐small cell lung cancer cell line (PC‐9/CDDP) selected from the wild type (PC‐9) for acquired resistance to cisplatin. PC‐9/CDDP demonstrated 28‐fold resistance to cisplatin, with cross resistance to other chemot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujiwara, Yasuhiro, Sugimoto, Yoshikazu, Kasahara, Kazuo, Bungo, Masami, Yamakido, Michio, Tew, Kenneth D., Saijo, Nagahiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1990
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918066/ https://www.ncbi.nlm.nih.gov/pubmed/2116401 http://dx.doi.org/10.1111/j.1349-7006.1990.tb02602.x

Ejemplares similares

Reversal of Cisplatin Resistance with Amphotericin B in a Non‐small Cell Lung Cancer Cell Line
por: Morikage, Toshihiko, et al.
Publicado: (1991)

The Mechanism of the Difference in Cellular Uptake of Platinum Derivatives in Non‐small Cell Lung Cancer Cell Line (PC‐14) and Its Cisplatin‐resistant Subline (PC‐14/CDDP)
por: Ohmori, Tohru, et al.
Publicado: (1993)

Detection of Proteins that Recognize Platinum‐modified DNA Using Gel Mobility Shift Assay
por: Fujiwara, Yasuhiro, et al.
Publicado: (1990)

Inhibition of Colony Formation of Drug‐resistant Human Tumor Cell Lines by Combinations of Interleukin‐2‐activated Killer Cells and Antitumor Drugs
por: Ohtsu, Atsushi, et al.
Publicado: (1989)

Cross-resistance to tumour promoters in human cancer cell lines resistant to adriamycin or cisplatin.
por: Nishio, K., et al.
Publicado: (1990)

Preferential Binding of E7010 to Murine β3‐Tubulin and Decreased β3‐Tubulin in E7010‐resistant Cell Lines
por: Iwamoto, Yasuo, et al.
Publicado: (1998)

LEVELS OF GLUTATHIONES TRANSFERASE π mRNA IN HUMAN LUNG CANCER CELL LINES CORRELATE WITH THE RESISTANCE TO CISPLATIN AND CARBOPLATIN
por: Nakagawa, Kazuhiko, et al.
Publicado: (1988)

In vitro and in vivo Effects of Cisplatin and Etoposide in Combination on Small Cell Lung Cancer Cell Lines
por: Kondo, Hideki, et al.
Publicado: (1994)

Rapid Polymerase Chain Reaction Assay to Detect Variation in the Extent of Gene‐specific Damage between Cisplatin‐ or VP‐16‐resistant and Sensitive Lung Cancer Cell Lines
por: Oshita, Fumihiro, et al.
Publicado: (1994)

Prognostic Significance of p53 and ras Gene Abnormalities in Lung Adenocarcinoma Patients with Stage I Disease after Curative Resection
por: Isobe, Takeshi, et al.
Publicado: (1994)

Phase I Study and Clinical Pharmacological Evaluation of Daily Oral Etoposide Combined with Carboplatin in Patients with Lung Cancer
por: Ohune, Terumasa, et al.
Publicado: (1995)

No Alteration in DNA Topoisomerase I Gene Related to CPT‐11 Resistance in Human Lung Cancer
por: Ohashi, Nobuyuki, et al.
Publicado: (1996)

Differential Expression of DNA Topoisomerase IIα and IIβ Genes between Small Cell and Non‐small Cell Lung Cancer
por: Syahruddin, Elisna, et al.
Publicado: (1998)

Enhanced Anti‐tumor Effect of Trastuzumab in Combination with Cisplatin
por: Naruse, Ichiro, et al.
Publicado: (2002)

Intracellular Carboxyl Esterase Activity Is a Determinant of Cellular Sensitivity to the Antineoplastic Agent KW‐2189 in Cell Lines Resistant to Cisplatin and CPT‐11
por: Ogasawara, Hayato, et al.
Publicado: (1995)

Alteration of Type II Regulatory Subunit of cAMP‐dependent Protein Kinase in Human Cisplatin‐resistant Cells as a Basis of Collateral Sensitivity to 8‐Chloro‐cAMP
por: Nishio, Kazuto, et al.
Publicado: (1992)

The Role of Pharmacoethnicity in the Development of Cytotoxic and Molecular Targeted Drugs in Oncology
por: Saijo, Nagahiro
Publicado: (2013)

Reversal of Cisplatin Resistance by the 1,4‐Benzothiazepine Derivative, JTV‐519
por: Nakamura, Takashi, et al.
Publicado: (2001)

Enhancement of Tumor Radio‐response by Irinotecan in Human Lung Tumor Xenografts
por: Tamura, Kenji, et al.
Publicado: (1997)

The Role of Glucuronidation in 7‐Ethyl‐10‐hydroxycamptothecin Resistance in vitro
por: Takahashi, Toshiaki, et al.
Publicado: (1997)

Prospective Evaluation of the Feasibility of Cisplatin‐based Chemotherapy for Elderly Lung Cancer Patients with Normal Organ Functions
por: Oshita, Fumihiro, et al.
Publicado: (1995)

Enhancement of Cisplatin Sensitivity in High Mobility Group 2 cDNA‐transfected Human Lung Cancer Cells
por: Arioka, Hitoshi, et al.
Publicado: (1999)

Characterization of a Human Small‐cell Lung Cancer Cell Line Resistant to a New Water‐soluble Camptothecin Derivative, DX‐8951f
por: Nomoto, Taisuke, et al.
Publicado: (1998)

Mechanisms of collateral sensitivity to fluorouracil of a cis-diamminedichloroplatinum(II)-resistant human non-small lung cancer cell line.
por: Sugimoto, Y., et al.
Publicado: (1992)

Cyclooxygenase‐2 (COX‐2) mRNA Expression Levels in Normal Lung Tissues and Non‐small Cell Lung Cancers
por: Ochiai, Mari, et al.
Publicado: (1999)

Correlation of Gene‐specific Damage with Cisplatin between Human Adenocarcinoma Cells and Peripheral Blood Mononuclear Cells Analyzed by Polymerase Chain Reaction‐stop Assay
por: Oshita, Fumihiro, et al.
Publicado: (1995)

Characterization of a Taxol‐resistant Human Small‐cell Lung Cancer Cell Line
por: Ohta, Sei, et al.
Publicado: (1994)

Expression of gamma-glutamylcysteine synthetase (gamma-GCS) and multidrug resistance-associated protein (MRP), but not human canalicular multispecific organic anion transporter (cMOAT), genes correlates with exposure of human lung cancers to platinum drugs.
por: Oguri, T., et al.
Publicado: (1998)

A novel SCID Mouse Model for Studying Spontaneous Metastasis of Human Lung Cancer to Human Tissue
por: Teraoka, Seigo, et al.
Publicado: (1995)

Present Status and Problems on Molecular Targeted Therapy of Cancer
por: Saijo, Nagahiro
Publicado: (2012)

Highlights for ESMO 40: celebration review for lifetime achievement awards
por: Saijo, Nagahiro
Publicado: (2016)

Specific Growth Inhibition of Small‐cell Lung Cancer Cells by Adenovirus Vector Expressing Antisense c‐kit Transcripts
por: Yamanishi, Yuji, et al.
Publicado: (1996)

Serial Measurement of Sister Chromatid Exchanges in the Peripheral Lymphocytes of Patients with Lung Cancer Receiving Chemotherapy in Relation to Bone Marrow Toxicity
por: Shinkai, Tetsu, et al.
Publicado: (1989)

Differential Expression of Facilitative Glucose Transporter (GLUT) Genes in Primary Lung Cancers and Their Liver Metastases
por: Kurata, Takayasu, et al.
Publicado: (1999)

Effect of Glutathione Depletion on Cisplatin Resistance in Cancer Cells Transfected with the γ‐Glutamylcysteine Synthetase Gene
por: Kurokawa, Hirokazu, et al.
Publicado: (1997)

Comment on: Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study: reply
por: Nakaoka, Yoshikazu, et al.
Publicado: (2020)

Basic Design Considerations for Clinical Trials in Oncology
por: Piantadosi, Steven, et al.
Publicado: (1992)

Guidelines for Analysis and Reporting of Clinical Trials in Oncology
por: Piantadosi, Steven, et al.
Publicado: (1993)

In vitro Enhancement of Antitumor Activity of a Water‐soluble Duocarmycin Derivative, KW‐2189, by Caffeine‐mediated DNA‐repair Inhibition in Human Lung Cancer Cells
por: Ogasawara, Hayato, et al.
Publicado: (1997)

The Mechanism of Acquired Resistance to Cisplatin by a Human Ovarian Cancer Cell Line
por: Kikuchi, Yoshihiro, et al.
Publicado: (1988)

Cannot write session to /tmp/vufind_sessions/sess_id706mnll74acemasj07g8n4d1